Fulcrum Therapeutics Inc Dividends

The next dividend date for Fulcrum Therapeutics Inc has not yet been scheduled.

What is a Dividend Date

When we talk about a dividend date, we’re referring specifically to the ex-dividend date.

This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.

The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.

Most brokerages will automatically credit the dividend to your account once it’s issued.

Historical Dividends for Fulcrum Therapeutics Inc (FULC)

No Results.
DateDeclaration DateRecord DatePayment DateAmount
No Results.

More About Fulcrum Therapeutics Inc

Country
USA
Full Time Employees
45

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its clinical-stage product candidate is pociredir, a fetal hemoglobin inducer, which is in phase 1b clinical trial for the treatment of sickle cell disease and beta-thalassemia. The company also discovers drug targets for potential treatment inherited aplastic anemias, such as of diamond-blackfan anemia, shwachman-diamond syndrome, and fanconi anemia, as well as novel fetal hemoglobin inducers, fibrotic disorders, and cardiomyopathies which is in preclinical trial. It has collaboration and license agreement with MyoKardia, Inc. to identify biological targets that are capable of modulating genes of interest with relevance to cardiomyopathies; and licensce agreement with CAMP4 which includes certain small molecule compounds, composition of matter and method of use patent rights, and know-how to research, develop, manufacture, use, and commercialize; and Sanofi for the development and commercialization of losmapimod, an oral small molecule being investigated for the treatment of facioscapulohumeral muscular dystrophy. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Owning Fulcrum Therapeutics Inc Stock on the Dividend Date

If you own Fulcrum Therapeutics Inc stock on the ex-dividend date, then you earn the associated dividend.

Theoretically, the price of Fulcrum Therapeutics Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Fulcrum Therapeutics Inc stock).

Therefore, it is typically not expected that there is any incremental profit to be gained from buying Fulcrum Therapeutics Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Fulcrum Therapeutics Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.

Learning More Fulcrum Therapeutics Inc Dividends

You can contact us any time if you would like to ask questions about Fulcrum Therapeutics Inc dividends or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.